220,000 patients in Japan, with an entry to tha

220,000 patients in Japan, with an entry to that market in a non-surgical procedure for Treating Inflammatory Bowel Disease (IBD) Without
Colectomy....i would say that's a great opportunity....its good news, very good news....but few are selling this stock and hence why we see a big movement downward with any sale....just like we saw the upward movements before the first dividend.....


Creekrat posted:
Yeah this was a "news day", but very ho hum news at that. I almost think it would have been better to have had no news. People are really wanting to get word on new acquisitions, and more info on NGIO.